Metachronous polyps in patients with clinically significant serrated polyps: Differences between microvesicular and goblet cell-rich hyperplastic polyps: A cohort study
Endoscopy · 01.06.2026 · 58 (S 03 S 03) · S978
DOI: 10.1055/s-0046-1822604 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Endoscopy, erschienen am 01.06.2026. Verfasst von O Toyoshima und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
The occurrence and detection of metachronous colorectal tumors are important for determining appropriate intervals of surveillance colonoscopy for polyps. Clinically significant serrated polyps (CSSPs) include sessile serrated lesions (SSLs), traditional serrated adenomas, hyperplastic polyps (HPs)≥10 mm, and proximal HPs of 5–9 mm. CSSPs are associated with the metachronous large, serrated polyps, which are at risk for colorectal cancer. Meanwhile, HPs are subclassified in the WHO classification into microvesicular HPs (MVHPs) and goblet cell-rich HPs (GCHPs). MVHPs and GCHPs differ in molecular biological behavior, histology, and endoscopic findings, and MVHPs have been shown to resemble SSLs. To date, no studies have compared the metachronous tumors of SSLs, MVHPs, and GCHPs among CSSPs; thus, we investigated the metachronous polyps.
Methods
This study was a single-center cohort study conducted at Toyoshima Endoscopy Clinic. We obtained data from the Toyoshima Endoscopy Clinic Database. This study was approved by the institutional review board of the Yoyogi Mental Clinic (approval no. RKK227). We evaluated patients who underwent their first (index) and second (surveillance) colonoscopy at the Toyoshima Endoscopy Clinic between April 2017 and August 2024. HPs that met the CSSP criteria (i.e.,≥10 mm or≥5 mm at proximal colon) were enrolled in this study. We assessed the effect of detection rates of SSLs, MVHPs, and GCHPs at index colonoscopy on the time to detections of metachronous SSLs, MVHPs, GCHPs, and adenomas. Hazard ratios (HRs) were calculated to adjust for age and sex using Cox proportional hazards models.
Results
A total of 3174 patients (male sex, 43.6%; mean age, 51.2 years; median surveillance period, 499 days) were enrolled. A family history of colorectal cancer was present in 7.56% of patients. Detection rates of SSLs, MVHPs, GCHPs, and conventional adenomas were 7.69%, 5.36%, 0.54%, and 56.76%, respectively. The detection rate of SSLs at index colonoscopy was associated with the detection of metachronous SSLs (HR 6.19, odds ratio [OR] 4.51-8.50, P
Zitieren
APA
Toyoshima, O., Nishizawa, T., & Hata, K. (2026). Metachronous polyps in patients with clinically significant serrated polyps: Differences between microvesicular and goblet cell-rich hyperplastic polyps: A cohort study. Endoscopy, 58(S 03 S 03), S978. https://doi.org/10.1055/s-0046-1822604
Vancouver
Toyoshima O, Nishizawa T, Hata K. Metachronous polyps in patients with clinically significant serrated polyps: Differences between microvesicular and goblet cell-rich hyperplastic polyps: A cohort study. Endoscopy. 2026;58(S 03 S 03):S978. doi:10.1055/s-0046-1822604
BibTeX
@article{Toyoshima2026,
author = {Toyoshima, O and Nishizawa, T and Hata, K},
title = {Metachronous polyps in patients with clinically significant serrated polyps: Differences between microvesicular and goblet cell-rich hyperplastic polyps: A cohort study},
journal = {Endoscopy},
year = {2026},
volume = {58},
number = {S 03 S 03},
pages = {S978},
doi = {10.1055/s-0046-1822604}
}
EUVIMED